BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30770506)

  • 41. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.
    Baker JF; Conaghan PG; Emery P; Baker DG; Østergaard M
    Ann Rheum Dis; 2016 Jun; 75(6):1114-9. PubMed ID: 26091907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up.
    Ramírez J; Narváez JA; Ruiz-Esquide V; Hernández-Gañán J; Cuervo A; Inciarte-Mundo J; Hernández MV; Sampayo-Cordero M; Pablos JL; Sanmartí R; Cañete JD
    Semin Arthritis Rheum; 2017 Dec; 47(3):303-309. PubMed ID: 28549731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative and semiquantitative bone erosion assessment on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis.
    Srikhum W; Virayavanich W; Burghardt AJ; Yu A; Link TM; Imboden JB; Li X
    J Rheumatol; 2013 Apr; 40(4):408-16. PubMed ID: 23418386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
    Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
    Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage.
    Krabbe S; Bolce R; Brahe CH; Døhn UM; Ejbjerg BJ; Hetland ML; Sasso EH; Chernoff D; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller J; Østergaard M
    Scand J Rheumatol; 2017 Sep; 46(5):353-358. PubMed ID: 27682742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of tocilizumab on MRI-determined bone oedema in rheumatoid arthritis.
    Bensaoud N; Rostom S; Bahiri R; Hajjaj-Hassouni N
    Clin Rheumatol; 2015 Jun; 34(6):1031-7. PubMed ID: 25903819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients with rheumatoid arthritis in clinical remission manifest persistent joint inflammation on histology and imaging studies.
    Anandarajah A; Thiele R; Giampoli E; Monu J; Seo GS; Feng C; Ritchlin CT
    J Rheumatol; 2014 Nov; 41(11):2153-60. PubMed ID: 25274900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of abatacept in patients with rheumatoid arthritis, as assessed by magnetic resonance imaging of bilateral hands.
    Kukida Y; Kasahara A; Seno T; Inoue T; Sagawa R; Kida T; Nakabayashi A; Nagahara H; Murakami K; Sugitani T; Morita S; Ito H; Oda R; Fujiwara H; Kohno M; Kawahito Y
    Int J Rheum Dis; 2018 Sep; 21(9):1678-1685. PubMed ID: 28730687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computer-aided and manual quantifications of MRI synovitis, bone marrow edema-like lesions, erosion and cartilage loss in rheumatoid arthritis of the wrist.
    Yang H; Rivoire J; Hoppe M; Srikhum W; Imboden J; Link TM; Li X
    Skeletal Radiol; 2015 Apr; 44(4):539-47. PubMed ID: 25488101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.
    Gandjbakhch F; Haavardsholm EA; Conaghan PG; Ejbjerg B; Foltz V; Brown AK; Døhn UM; Lassere M; Freeston JE; Olsen IC; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen FM; Østergaard M
    J Rheumatol; 2014 Feb; 41(2):398-406. PubMed ID: 24334647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advantages of a combined rheumatoid arthritis magnetic resonance imaging score (RAMRIS) for hand and feet: does the RAMRIS of the hand alone underestimate disease activity and progression?
    Sewerin P; Buchbender C; Vordenbäumen S; Scherer A; Miese F; Brinks R; Wittsack HJ; Klein S; Schneider M; Antoch G; Ostendorf B
    BMC Musculoskelet Disord; 2014 Mar; 15():104. PubMed ID: 24669889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
    Conaghan PG; O'Connor P; McGonagle D; Astin P; Wakefield RJ; Gibbon WW; Quinn M; Karim Z; Green MJ; Proudman S; Isaacs J; Emery P
    Arthritis Rheum; 2003 Jan; 48(1):64-71. PubMed ID: 12528105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis.
    Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TW; Wong DA; Conaghan PG; Emery P
    Ann Rheum Dis; 2016 Aug; 75(8):1501-5. PubMed ID: 26865601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of magnetic resonance imaging in detecting subclinical synovitis in rheumatoid arthritis and correlation of imaging findings with interleukin-18 levels.
    Chew LC; Chandra Mohan P; Chan LP; Fong KY; Thumboo J
    Int J Rheum Dis; 2016 Aug; 19(8):790-8. PubMed ID: 25123522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
    Forslind K; Svensson B
    Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation.
    Tam LS; Griffith JF; Yu AB; Li TK; Li EK
    Clin Rheumatol; 2007 Jun; 26(6):941-6. PubMed ID: 16868816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.
    Woodworth TG; Morgacheva O; Pimienta OL; Troum OM; Ranganath VK; Furst DE
    Rheumatology (Oxford); 2017 Jul; 56(7):1177-1188. PubMed ID: 28398508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.